VALEO PHARMA INC News

VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS

Yahoo FinanceApr 25 17:55 ET

VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE

Yahoo FinanceApr 9 07:00 ET

Stocks in Play: Valeo Pharma Inc.

Baystreet.caMar 22 09:42 ET

Valeo Pharma Reports Q1 Results

Seeking AlphaMar 15 09:39 ET

VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTS

Yahoo FinanceMar 14 17:29 ET

VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST

Yahoo FinanceMar 7 07:00 ET

VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2023 RESULTS CONFERENCE CALL / WEBCAST

Yahoo FinanceJan 22 07:00 ET

Analysts Just Shaved Their Valeo Pharma Inc. (TSE:VPH) Forecasts Dramatically

Yahoo FinanceSep 21, 2023 14:15 ET

It's Down 29% But Valeo Pharma Inc. (TSE:VPH) Could Be Riskier Than It Looks

Yahoo FinanceJun 8, 2023 06:01 ET

Valeo Pharma Reports Q2 Results

Seeking AlphaMay 25, 2023 09:32 ET

Valeo Pharma Sees Q2 Revenue Above Estimates

Seeking AlphaMay 25, 2023 07:33 ET

Valeo Pharma to Webcast Live at VirtualInvestorConferences.com March 9th

MONTREAL, March 06, 2023 (GLOBE NEWSWIRE) -- Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF, FSE: VP2)) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Steve Saviuk, CEO, will present live

GlobeNewswireMar 6, 2023 08:37 ET

Valeo Pharma Reports Q4 Results

Seeking AlphaJan 30, 2023 17:31 ET

Great News for Valeo Pharma Inc. (TSE:VPH): Insiders Acquired Stock in Large Numbers Last Year

Yahoo FinanceDec 18, 2022 09:31 ET

Valeo Pharma Raises Q4 Revenue Guidance

Seeking AlphaNov 15, 2022 08:13 ET

Valeo Pharma Reports Q3 Results

Valeo Pharma press release (OTCQB:VPHIF): Q3 Revenue of $6.1M beats by $1.41M. Cash and liquidities of $27.7 million as at July 31, 2022

Seeking AlphaSep 13, 2022 17:32 ET

Valeo Pharma reports Q2 results

Valeo Pharma press release (OTCQB:VPHIF): Q2 Net loss was C$5.1M Revenue of C$4.8M (+81.1% Y/Y).

Seeking AlphaJun 14, 2022 21:14 ET

CSE Bulletin: Delist - Valeo Pharma Inc. (VPH, VPH.WT, VPH.WT.A)

Toronto, Ontario--(Newsfile Corp. - le 25 mars/March 2022) - At the request of the company the common shares and warrants of Valeo Pharma Inc. will be delisted at market close on March 28, 2022.

newsfileMar 25, 2022 11:30 ET

Valeo Pharma net loss of C$5.9M, revenue of C$4.2M

Valeo Pharma press release (OTCQB:VPHIF): FQ1 net loss of C$5.9M.Revenue of C$4.2M (+121.1% Y/Y).

Seeking AlphaMar 24, 2022 18:12 ET

Valeo Pharma reports Q4 results

Valeo Pharma press release (OTCQB:VPHIF): Q4 Adjusted EBITDA loss of $5.4M compared to $0.5M in Q4 2020.Revenue of $3.4M (+54.5% Y/Y) misses by $0.81M.Gross margin was $0.7M for the quarter ended Oct

Seeking AlphaMar 1, 2022 05:06 ET